A Phase 1, Pilot, Single-Dose, 3-Way Crossover Study to Compare the Pharmacokinetics of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production
Phase of Trial: Phase I
Latest Information Update: 14 Apr 2017
At a glance
- Drugs AC 1202 (Primary) ; AC 1204 (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Accera
- 10 Apr 2017 Status changed from active, no longer recruiting to completed.
- 06 Feb 2017 Status changed from recruiting to active, no longer recruiting.
- 14 Nov 2016 New trial record